90 related articles for article (PubMed ID: 17339240)
1. Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.
Brueckmann M; Borggrefe M
Gut; 2007 Mar; 56(3):314-6. PubMed ID: 17339240
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.
Vitale S; Cambien B; Karimdjee BF; Barthel R; Staccini P; Luci C; Breittmayer V; Anjuère F; Schmid-Alliana A; Schmid-Antomarchi H
Gut; 2007 Mar; 56(3):365-72. PubMed ID: 16870716
[TBL] [Abstract][Full Text] [Related]
3. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea.
Gangemi S; Cannavò SP; Guarneri F; Merendino RA; Sturniolo GC; Minciullo PL; Di Pasquale G; Valenzise M; Drago F; Rebora A
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1366-7. PubMed ID: 17062081
[No Abstract] [Full Text] [Related]
4. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
[TBL] [Abstract][Full Text] [Related]
5. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
[TBL] [Abstract][Full Text] [Related]
6. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
[TBL] [Abstract][Full Text] [Related]
7. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine: moving from chemotaxis to neuroprotection.
Ré DB; Przedborski S
Nat Neurosci; 2006 Jul; 9(7):859-61. PubMed ID: 16801915
[No Abstract] [Full Text] [Related]
9. Fractalkine mediates natural killer-dependent antitumor responses in vivo.
Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C
Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547
[TBL] [Abstract][Full Text] [Related]
10. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices.
Bertollini C; Ragozzino D; Gross C; Limatola C; Eusebi F
Neuropharmacology; 2006 Sep; 51(4):816-21. PubMed ID: 16815480
[TBL] [Abstract][Full Text] [Related]
12. [Adhesional chemokine, fractalkine].
Umehara H
Nihon Rinsho Meneki Gakkai Kaishi; 2000 Apr; 23(2):90-102. PubMed ID: 10863324
[No Abstract] [Full Text] [Related]
13. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
[TBL] [Abstract][Full Text] [Related]
14. The CX3CL1-CX3CR1 system and psoriasis.
Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
[TBL] [Abstract][Full Text] [Related]
15. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
16. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
Harcourt JL; Karron RA; Tripp RA
J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the 3' untranslated region of the fractalkine (CX3CL1) gene and the risk of HIV-1 infection and disease progression.
Peraire J; Vidal F; Plana M; Domingo P; Coll B; Viladés C; Garcia F; Veloso S; Gatell JM; Broch M
AIDS; 2007 Apr; 21(7):891-3. PubMed ID: 17415055
[No Abstract] [Full Text] [Related]
18. Fractalkine expression in the rhesus monkey brain during lentivirus infection and its control by 6-chloro-2',3'-dideoxyguanosine.
Depboylu C; Eiden LE; Schäfer MK; Reinhart TA; Mitsuya H; Schall TJ; Weihe E
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1170-80. PubMed ID: 17146291
[TBL] [Abstract][Full Text] [Related]
19. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
[TBL] [Abstract][Full Text] [Related]
20. Generation and analysis of mice lacking the chemokine fractalkine.
Cook DN; Chen SC; Sullivan LM; Manfra DJ; Wiekowski MT; Prosser DM; Vassileva G; Lira SA
Mol Cell Biol; 2001 May; 21(9):3159-65. PubMed ID: 11287620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
